menu
    • menu

    Company profile for Clearmind Medicine

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Clearmind Medicine (CSE: CMND) develops novel psychedelic medicines to solve widespread, yet under-served, health problems. With a strong medical management team and IP-protection, we can better the lives of millions. With a clear focus on alcohol abuse and binge drinking, Clearmind's first drug candidate addresses very common (and costly) afflictions which to date, have limited solutions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Clearmind MedicineCanada Flag
    Country
    Country
    Canada
    Address
    Address
    101 – 1220 W 6 Ave Vancouver, BC V6H1A5
    Telephone
    Telephone
    (778) 400 5347
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.clearmindmedicine.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clearmind-medicine/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clearmind Medicine Announces 1-For-40 Reverse Share Split
    Clearmind Medicine Announces 1-For-40 Reverse Share Split

    10 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/10/3203513/0/en/Clearmind-Medicine-Announces-1-for-40-Reverse-Share-Split.html

    GLOBENEWSWIRE
    10 Dec 2025
    Share Share
    Clearmind Pharma Receives Nasdaq Minimum Bid Price Notice
    Clearmind Pharma Receives Nasdaq Minimum Bid Price Notice

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200998/0/en/Clearmind-Medicine-Announces-Receipt-of-Nasdaq-Minimum-Bid-Price-Notification.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share
    Clearmind Medicine Charges Forward in Alcoholism Treatment
    Clearmind Medicine Charges Forward in Alcoholism Treatment

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197063/0/en/Clearmind-Medicine-Charges-Forward-in-Alcoholism-Treatment-Positive-Cohort-Data-Full-DSMB-Approval-and-New-Elite-Site-Joins-the-Clinical-Trial.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Clearmind Medicine Starts AUD Trial in Tel Aviv Clinic
    Clearmind Medicine Starts AUD Trial in Tel Aviv Clinic

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194223/0/en/Clearmind-Medicine-Kicks-Off-Patient-Enrollment-at-Tel-Aviv-Sourasky-Medical-Center-Adding-Another-Site-Activated-in-its-in-Phase-I-IIa-Alcohol-Use-Disorder-Trial.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Clearmind DSMB OKs Ph1/2a CMND-100 Trial After Positive Review
    Clearmind DSMB OKs Ph1/2a CMND-100 Trial After Positive Review

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193523/0/en/Clearmind-Medicine-s-Data-and-Safety-Monitoring-Board-Unanimously-Approves-Continuation-of-Phase-I-IIa-Clinical-Trial-for-CMND-100-Following-Positive-Interim-Safety-Review.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Clearmind Adds Fifth Site to Accelerate FDA-Approved AUD Trial
    Clearmind Adds Fifth Site to Accelerate FDA-Approved AUD Trial

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191706/0/en/Clearmind-Medicine-Accelerate-FDA-Approved-Alcohol-Use-Disorder-Clinical-Trial-by-Activating-Fifth-Elite-Global-Medical-Site.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search